Strategy for characterization of paraproteins in the diagnosis of malignant monoclonal gammapathies (pages 7 to 13)
M. Marinkovi (Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Beograd, Serbia Montenegro)
Emerging role of target-based therapies for gastrointestinal malignancies (pages 15 to 21)
T. Dragovich (University of Arizona Cancer Center, Tucson, USA)
Alternative interventional multimodality therapies for the management of liver malignancies (pages 23 to 33)
D. K. Filippou (First Department of General Surgery, Tzaneio General Hospital, Piraeus, Greece), E. D. Avgerinos, E. Pavlakis, S. Rizos
New options in the treatment of myelodysplastic syndrome (pages 35 to 42)
J. Grudeva-Popova (Department of Hematology, Medical University-Plovdiv, Bulgaria)
Good Scientific Practice. Part VII. Underpublishing/underreporting research (pages 43 to 46)
L. Vukovi-Deki (Institute for Oncology and Radiology of Serbia, Beograd, Serbia and Montenegro)
Irinotecan plus weekly 5-fluorouracil and leucovorin as salvage treatment for patients with metastatic colorectal cancer A phase II trial (pages 47 to 52)
J. Souglakos (Department of Medical Oncology, University General Hospital of Heraklion, Heraklion, Crete, Greece), N. Vardakis, N. Androulakis, S. Kakolyris, Ch. Kouroussis, D. Mavroudis, A. Pallis, S. Agelaki, K. Kalbakis, V. Georgoulias
Primarily tamoxifen-unresponsive, steroid receptor-positive breast cancer may respond to an aromatase inhibition a pilot study (pages 53 to 58)
Z. Neskovi-Konstantinovi (Department of Medical Oncology, Institute of Oncology and Radiology of Serbia, Beograd, Serbia and Montenegro), S. Susnjar, D. Nikoli-Vukosavljevi, D. Jovanovi, S. Vasovi, L. Stamatovi, D. Gavrilovi
Beta-2 microglobulin in Hodgkin’s lymphoma prognostic significance in patients treated with ABVD or equivalent regimens (pages 59 to 69)
T. P. Vassilakopoulos (Hematology Section, First Department of Internal Medicine, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece), G. Nadali, M. K. Angelopoulou, M. N. Dimopoulou, M. P. Siakantaris, F. N. Kontopidou, C. Karkantaris, S. I. Kokoris, E. M. Dimitriadou, C. Calpadaki, A. Sarantopoulos, Z. Galani, S. Sachanas, M. C. Kyrtsonis, P. Tsaftaridis, E. Variamis, P. Panayotidis, G. Pizzolo, A. H. Sarris, G. A. Pangalis
N. Tsavaris (Departments of Pathophysiology-Medical Oncology Unit, Laikon University General Hospital, Athens University School of Medicine, Athens, Greece), C. Kosmas, N. Kavantzas, A. Lazaris, E. Skopelitis, A. Dimitrakopoulos, M. P. Siakantaris, E. Papalambros, N. Diamantis, E. Patsouris, G. A. Pangalis
Does epirubicin affect left ventricular systolic performance in oncologic patients (pages 77 to 80)
D. Radulescu (5th Medical Hospital, Medical University Cluj, Cluj, Romania), C. Duncea, T. E. Ciuleanu, L. I. Radulescu, T. Gal, I. Cimpean
E. Kyparidou (Department of Pathology, Agii Anargiri Cancer Hospital of Kifisia, Athens, Greece), A. Athanasiadis, E. Xydakis, M. Papadakou, G. Panagos
Octreotide neutralizes dexamethasone antitumor actions on P388 murine lymphocytic leukemia in vivo (pages 89 to 94)
D. T.P. Trafalis (1st Department of Medical Oncology, Metaxa Cancer Hospital, Piraeus, Greece), E. Chrysogelou, P. Dalezis, G. Geromichalos, M. Kontos, C. Andreadis, N. Ziras, M. Koutsilieris, A. E. Athanassiou, G. A. Pangalis, A. Papageorgiou
Does pentoxifylline increase radiation response of Ehrlich mammary carcinoma in mice (pages 95 to 98)
D. ksz (Department of Radiation Oncology, Cerrahpasa Medical Faculty, Istanbul, Turkey), N. Bee, T. Altug, M. enocak, B. M. Abidin, M. Belder, A. ber
Evaluation of sister chromatid exchanges, micronuclei, and proliferating rate index in hospital workers chronically exposed to ionizing radiation (pages 99 to 103)
J. Mrdjanovi (Department of Experimental Oncology, Institute of Oncology, Sremska Kamenica, Serbia and Montenegro), D. Jakimov, S. Turijan, G. Bogdanovi
Preliminary study of mononuclear phagocytosis during breast cancer therapy (pages 105 to 109)
N. Arsenijevi (Department of Microbiology and Immunology, University of Kragujevac, Kragujevac, Serbia and Montenegro), D. Baski, S. Popovi, P. Risti, L. Aimovi
A negative adaptive response is expressed in peripheral blood lymphocytes that are exposed to mitomycin C and cycloheximide (pages 111 to 117)
V. Baji (Institute for Biomedical Research, Galenika a.d. Beograd, Serbia and Montenegro), Z. Milicevi, B. Spremo-Potparevi
Early postoperative glutamine-supplemented parenteral nutrition versus enteral immunonutrition in cancer patients undergoing major gastrointestinal surgery (pages 119 to 122)
V. Alivizatos (Department of Surgery, Nutrition and Intestinal Failure Unit, Agios Andreas General Hospital, Patras, Greece), P. Athanasopoulos, N. Makris, N. Karageorgos
Fluoroscopy and Paget’s disease of the breast (pages 123 to 126)
C. L. Loizou (Cambridge Breast Unit, Addenbrooke’s Hospital, Cambridge, UK), D. Garner, A. D. Purushotham
Localized hyaline plaque of the diaphragmatic peritoneum report of a rare entity mimicking a hepatic tumor (pages 127 to 129)
A. Kondis Pafitis (Department of Pathology, Areteion University Hospital, Athens, Greece), K. Kontogianni, C. Gennatas, V. Smyrniotis
Melanosis coli in two patients with colorectal neoplasia (pages 131 to 133)
Ch. Tsobanidou (Department of Pathology, Hippokratio General Hospital, Thessaloniki, Greece)
Carcinoma of the prostate. A historical account (pages 135 to 144)
G. Androutsos (Institute of History of Medicine, University Claude Bernard, Lyon, France)
Could Chekhovian Humanism Help Us Today (pages 145 to 148)
Rajko Igi (Department of Anesthesiology and Pain Management, John H. Stroger Jr. Hospital of Cook County, Chicago, USA)
